The Pfizer/BioNTech Covid-19 Vaccine Is Less Effective Against The South African And UK Variants Than Against The Original Virus, According To A New “real-World” Study From Israel
Thanks to an extensive vaccination program in Israel and diligent follow-up of those vaccinated, we have a bigger glimpse of how the Pfizer/BioNTech is performing against variants.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
More News: African Health | COVID-19 | Israel Health | Middle East Health | Pfizer | Pharmaceuticals | South Africa Health | Study | Vaccines